<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />




<title>Haemodialysis</title>

<script src="site_libs/header-attrs-2.11/header-attrs.js"></script>
<script src="site_libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="site_libs/bootstrap-3.3.5/css/flatly.min.css" rel="stylesheet" />
<script src="site_libs/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="site_libs/jqueryui-1.11.4/jquery-ui.min.js"></script>
<link href="site_libs/tocify-1.9.1/jquery.tocify.css" rel="stylesheet" />
<script src="site_libs/tocify-1.9.1/jquery.tocify.js"></script>
<script src="site_libs/navigation-1.1/tabsets.js"></script>
<link href="site_libs/font-awesome-5.1.0/css/all.css" rel="stylesheet" />
<link href="site_libs/font-awesome-5.1.0/css/v4-shims.css" rel="stylesheet" />

<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>






<link rel="stylesheet" href="styles.css" type="text/css" />



<style type = "text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
img {
  max-width:100%;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
pre code {
  padding: 0;
}
</style>


<style type="text/css">
.dropdown-submenu {
  position: relative;
}
.dropdown-submenu>.dropdown-menu {
  top: 0;
  left: 100%;
  margin-top: -6px;
  margin-left: -1px;
  border-radius: 0 6px 6px 6px;
}
.dropdown-submenu:hover>.dropdown-menu {
  display: block;
}
.dropdown-submenu>a:after {
  display: block;
  content: " ";
  float: right;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
  border-width: 5px 0 5px 5px;
  border-left-color: #cccccc;
  margin-top: 5px;
  margin-right: -10px;
}
.dropdown-submenu:hover>a:after {
  border-left-color: #adb5bd;
}
.dropdown-submenu.pull-left {
  float: none;
}
.dropdown-submenu.pull-left>.dropdown-menu {
  left: -100%;
  margin-left: 10px;
  border-radius: 6px 0 6px 6px;
}
</style>

<script type="text/javascript">
// manage active state of menu based on current page
$(document).ready(function () {
  // active menu anchor
  href = window.location.pathname
  href = href.substr(href.lastIndexOf('/') + 1)
  if (href === "")
    href = "index.html";
  var menuAnchor = $('a[href="' + href + '"]');

  // mark it active
  menuAnchor.tab('show');

  // if it's got a parent navbar menu mark it active as well
  menuAnchor.closest('li.dropdown').addClass('active');

  // Navbar adjustments
  var navHeight = $(".navbar").first().height() + 15;
  var style = document.createElement('style');
  var pt = "padding-top: " + navHeight + "px; ";
  var mt = "margin-top: -" + navHeight + "px; ";
  var css = "";
  // offset scroll position for anchor links (for fixed navbar)
  for (var i = 1; i <= 6; i++) {
    css += ".section h" + i + "{ " + pt + mt + "}\n";
  }
  style.innerHTML = "body {" + pt + "padding-bottom: 40px; }\n" + css;
  document.head.appendChild(style);
});
</script>

<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before {
  content: "";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "&#xe258;";
  border: none;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
  background-color: transparent;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<!-- code folding -->



<style type="text/css">

#TOC {
  margin: 25px 0px 20px 0px;
}
@media (max-width: 768px) {
#TOC {
  position: relative;
  width: 100%;
}
}

@media print {
.toc-content {
  /* see https://github.com/w3c/csswg-drafts/issues/4434 */
  float: right;
}
}

.toc-content {
  padding-left: 30px;
  padding-right: 40px;
}

div.main-container {
  max-width: 1200px;
}

div.tocify {
  width: 20%;
  max-width: 260px;
  max-height: 85%;
}

@media (min-width: 768px) and (max-width: 991px) {
  div.tocify {
    width: 25%;
  }
}

@media (max-width: 767px) {
  div.tocify {
    width: 100%;
    max-width: none;
  }
}

.tocify ul, .tocify li {
  line-height: 20px;
}

.tocify-subheader .tocify-item {
  font-size: 0.90em;
}

.tocify .list-group-item {
  border-radius: 0px;
}

.tocify-subheader {
  display: inline;
}
.tocify-subheader .tocify-item {
  font-size: 0.95em;
}

</style>



</head>

<body>


<div class="container-fluid main-container">


<!-- setup 3col/9col grid for toc_float and main content  -->
<div class="row">
<div class="col-xs-12 col-sm-4 col-md-3">
<div id="TOC" class="tocify">
</div>
</div>

<div class="toc-content col-xs-12 col-sm-8 col-md-9">




<div class="navbar navbar-default  navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="index.html">Nephromancer</a>
    </div>
    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    U&amp;E
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./acidbase.html">H+ &amp; HCO3</a>
    </li>
    <li>
      <a href="./na.html">Na</a>
    </li>
    <li>
      <a href="./k.html">K</a>
    </li>
    <li>
      <a href="./mg.html">MG</a>
    </li>
    <li>
      <a href="./ca.html">Ca2+</a>
    </li>
    <li>
      <a href="./po4.html">PO4</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    GN
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./MCD.html">MCD</a>
    </li>
    <li>
      <a href="./ANCA.html">ANCA</a>
    </li>
    <li>
      <a href="./IGAN.html">IGAN</a>
    </li>
    <li>
      <a href="./aboutme.html">MG</a>
    </li>
    <li>
      <a href="./aboutme.html">Ca2+</a>
    </li>
    <li>
      <a href="./aboutme.html">PO4</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    CKD
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./aboutme.html">H+ &amp; HCO3</a>
    </li>
    <li>
      <a href="./aboutme.html">Na</a>
    </li>
    <li>
      <a href="./aboutme.html">K</a>
    </li>
    <li>
      <a href="./aboutme.html">MG</a>
    </li>
    <li>
      <a href="./aboutme.html">Ca2+</a>
    </li>
    <li>
      <a href="./renalbone.html">Renal-Bone</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    TX
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./project1.html">Cheat sheet</a>
    </li>
    <li>
      <a href="./project2.html">Project part 2</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    RRT
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./HD.html">HD</a>
    </li>
    <li>
      <a href="./aboutme.html">Home HD</a>
    </li>
    <li>
      <a href="./aboutme.html">HD Access</a>
    </li>
    <li>
      <a href="./aboutme.html">PD</a>
    </li>
    <li>
      <a href="./aboutme.html">CVVH</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    DRUGS
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./abx.html">Abx</a>
    </li>
    <li>
      <a href="./aboutme.html">HDU</a>
    </li>
    <li>
      <a href="./aboutme.html">K</a>
    </li>
    <li>
      <a href="./aboutme.html">MG</a>
    </li>
    <li>
      <a href="./aboutme.html">Ca2+</a>
    </li>
    <li>
      <a href="./aboutme.html">PO4</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    MISC
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./path.html">PATH</a>
    </li>
    <li>
      <a href="./project2.html">PEX</a>
    </li>
    <li>
      <a href="./Lymphoproliferative.html">Lymphoproliferative</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    EDU
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="./project1.html">Project part 1</a>
    </li>
    <li>
      <a href="./project2.html">Project part 2</a>
    </li>
  </ul>
</li>
      </ul>
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="https:eoindosullivan.com">
    <span class="fas fa-home"></span>
     
  </a>
</li>
      </ul>
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

<div id="header">



<h1 class="title toc-ignore">Haemodialysis</h1>

</div>


<div id="vaccinations" class="section level1">
<h1>Vaccinations</h1>
<p><strong>HEP B – 1/3 don’t respond. At 1 year, only about ~64% have
adequate Ab protection</strong></p>
<ul>
<li><strong>HBVAXPRO</strong> 40 micrograms at 0, 1 and 6 months by IM
injection. Not in buttocks – go deltoid – better response.</li>
<li><strong>Fendrix</strong> -20micrograms at 0,1,2 and 6 months</li>
<li><strong>Engerix</strong> B -40 micrograms at 0,1,2 and 6 months</li>
</ul>
<p>Check anti-Hbs antibodies 1-2 months after course.</p>
<ul>
<li><strong>Responder</strong>: &gt;100mIU/ml .</li>
<li><strong>Partial response</strong>: 10-100mIU/ml. Give booster (once)
and recheck in 1-2 months.</li>
<li><strong>Non response</strong>: &lt;10mIU/ml. Repeat entire course
once only. If still &lt;10mIU/ml, then patient is a ‘non responder’ and
move on. If level 10-100mIU/ml then treat as partial response.
<ul>
<li>If non response, check for ABsag and either proceed as acute
infection if + or “vulnerable”</li>
<li>HBIG postexposure prophylaxis for any known or likely parenteral
exposure to HBsAg positive blood is available.</li>
</ul></li>
<li>Once established, annual check with a booster if &lt;100mIu/ml.</li>
</ul>
<p><strong>Notes:</strong></p>
<ul>
<li>Better immune response and high rates of conversion if given before
ESKD</li>
<li>If started on normal dose pre HD but transitioning to HD during
vaccine course, increase to the double dose (40mg) once on HD</li>
<li>Ab tires &gt;10 are still protective</li>
</ul>
<p><strong>Other Vaccines</strong></p>
<ul>
<li>Annual inactivated influenza</li>
<li>Pneumococcal: Regime varies depending on history and PCV13/PPSV23:
See table 2 and table 3 of the appendix of CDC document <a
href="https://www.cdc.gov/dialysis/pdfs/vaccinating_dialysis_patients_and_patients_dec2012.pdf">here</a></li>
<li><a
href="https://www.gov.uk/government/collections/immunisation-against-infectious-disease-the-green-book#the-green-book">Green
book</a></li>
<li>COVID probably</li>
</ul>
</div>
<div id="dry-weight" class="section level1">
<h1>Dry weight</h1>
<ul>
<li>BP should be normal throughout, high post HD BP ?wet</li>
<li>Can take ~3 months to get to a first dry weight – persistence is
key</li>
<li>Early tapering of BP meds can help hit dry weight (evidence?)</li>
<li>Hypotension/cramps = refill capacity. Does not necessarily mean at
dry weight</li>
<li>BP normalisation can lag weeks after ECF volume normalisation
(?evidence)</li>
</ul>
</div>
<div id="adequacy" class="section level1">
<h1>Adequacy</h1>
<p><strong>URR:</strong> ((Pre urea-post urea)*100)/Pre-urea</p>
<ul>
<li>Underestimates due to ignoring urea clearance during UF and intra HD
urea generation</li>
<li>Target 70%. Mostly a Fn of Qb and Time</li>
</ul>
<p><strong>Single Pool Kt/V</strong></p>
<ul>
<li><p>Accounts of size by using TBW in formula</p></li>
<li><p>Urea Clearance(K)*Time(T)/Vd of Urea (55% TBW in men, 50% in
women)</p></li>
<li><p>Target 1.4, min 1.2</p></li>
</ul>
<p><strong>Equilibrated Kt/V</strong></p>
<ul>
<li><p>Optimal</p></li>
<li><p>Wait 30 mins for equilibration before second sample</p></li>
</ul>
<br>
<style>
div.blue { background-color:#e6f0ff; border-radius: 5px; padding: 20px;}
</style>
<div class="blue">
<p><a
href="https://www.nejm.org/doi/full/10.1056/nejmoa021583">HEMO</a></p>
<ul>
<li><p>1846 patients 3*week HD</p></li>
<li><p>Primary outcome: death</p></li>
<li><p>Secondary outcome: hospitalization for cardiac causes or death
from any cause, first hospitalization for infection or death from any
cause, first 15 percent decrease in the serum albumin level or death
from any cause, and all hospitalizations not related to vascular
access</p></li>
<li><p>Results: No difference between high dose (Kt/v 1.7, URR 75) vs
low (Kt/V 1.16, URR 66). No difference between high flux and low
flux.</p></li>
</ul>
</div>
<p><br></p>
</div>
<div id="iron" class="section level1">
<h1>Iron</h1>
<ul>
<li>Screen annually in CKD G3, biannually in CKD G4</li>
<li>Investigate - EPO def is dx of exclusion. “possible”” in eGFR
&lt;60, “probable” in &lt;30</li>
</ul>
<div id="iron-studies" class="section level4">
<h4>Iron studies</h4>
<ul>
<li>% HRC if able to process within 6 hours</li>
<li>Reticulocyte Hb count (CHr)</li>
<li>TSATS and ferritin ( if above not available or thalassaemia)</li>
<li>Ferritin &amp; CRP</li>
<li>PTH &amp; TFT ( can contribute to iron def)</li>
<li>Consider - b12/folate/haemolysis/plasma&amp;urine electrophroesis,
hb electrophoresis, LTC &amp; Marrow</li>
<li>Scopes etc</li>
</ul>
</div>
<div id="iron-repletion" class="section level4">
<h4>Iron repletion</h4>
<ul>
<li>%HRC &lt;6% / CHr &gt;29 pg / ferritin and TSAT (&gt;100 microgram/L
and &gt;20%).</li>
<li>Oral iron usually ok for CKD, PD. IV for HD.</li>
<li>If not in centre, high dose low frequency is good</li>
</ul>
</div>
<div id="iron-therapy" class="section level4">
<h4>Iron Therapy</h4>
<ul>
<li><p>In HD proactive high-dose IV iron sucrose (venofer) 400 mg every
month (or equivalent) should be given unless ferritin &gt; 700 μg/L or
TSAT&gt;40% ( PIVITOL)</p></li>
<li><p>Avoid in infection, probably</p></li>
<li><p>Monitor quarterly</p></li>
<li><p>Hb Targets: 100-120</p></li>
<li><p>Caution in malignancy</p></li>
<li><p><strong>Limits</strong> Feritin =&lt; 800. Review iron therapy
when hits 500.</p></li>
</ul>
<p>In Edinburgh use iron as ferric derisomaltose (Diafer) ~100mg
weekly/monthly etc during HD. This is low dose :(</p>
<br>
<style>
div.blue { background-color:#e6f0ff; border-radius: 5px; padding: 20px;}
</style>
<div class="blue">
<p><a
href="https://www.nejm.org/doi/full/10.1056/nejmoa1810742">PIVOTAL</a></p>
<ul>
<li>High dose IV iron vs low dose</li>
<li>High dose non inferior for compositive CV | death endpoint</li>
<li>Less CV composite events in high dose hazard ratio, 0.80; 95% CI,
0.64 to 1.00</li>
<li>Less Blood transfusions</li>
<li>Same infections</li>
</ul>
</div>
<p><br></p>
</div>
</div>
<div id="esa" class="section level1">
<h1>ESA</h1>
<ul>
<li>Caution htn - 175/95 as arbitrary cut offs</li>
<li>Neorecoromon is 150 units/kg body weight/week. This is usually
administered as 3 divided doses (but can be given as a single weekly
dose), given intravenously during haemodialysis. 70kg man gets 3500
units each session (10,500/3)</li>
<li>Adjust in 25-50% increments</li>
</ul>
<div id="resistance-to-esa-therapy" class="section level4">
<h4>Resistance to ESA therapy</h4>
<p>Failure to reach the target Hb level despite SC epoetin dose &gt;300
IU/kg/week (450 IU/kg/week IV epoetin), or darbepoetin dose &gt;1.5
microgram/kg/week. ( 70kg man = 7000 units/session)</p>
<p>Hyporesponsive patients who are iron replete should be screened
clinically and by investigations for other common causes of anaemia.</p>
</div>
<div id="pure-red-cell-aplasia" class="section level4">
<h4>Pure Red Cell Aplasia</h4>
<p>Considered whenever a patient receiving long term ESA therapy (more
than 8 weeks) develops all the following (2A):</p>
<ul>
<li>sudden decrease in Hb concentration at the rate of 5 to 10g/L per
week OR requirement of transfusions at the rate of approximately 1 to 2
per week</li>
<li>normal platelet and white cell counts,</li>
<li>absolute reticulocyte count less than 10,000/µl</li>
</ul>
<p>ESA therapy should be stopped in patients who develop ESA induced
PRCA.</p>
<p>Patients who remain transfusion dependent after withdrawing ESA
therapy should be treated with immunosuppressant medications guided by
the level of anti EPO antibodies</p>
</div>
</div>
<div id="hd-prescription-tips" class="section level1">
<h1>HD Prescription tips</h1>
<ul>
<li>Lower temps = greater tolerability and possibly CV/Neuro
outcomes</li>
<li>Qb 300-500, Qd 500-800</li>
<li>Initiation: 2hr Qb200 Qd500 ,3hr Qb250 Qd500 ,4hrs Qb300 Qd800.</li>
<li>Never use a 0 K+ bath (if its even an option) – too much K flux</li>
<li>Post Tx: avoid hypotension (assoc. with increase risk of acute
rejection)</li>
<li>Acidaemic: Check ionised Calcium – the incoming bicarb load will
drop the iCa - &gt;seizures etc</li>
</ul>
</div>
<div id="severe-uraemia" class="section level1">
<h1>Severe Uraemia</h1>
<ul>
<li>Pericarditis is a clinical diagnosis</li>
<li><strong>Rx:</strong>* Daily HD, no anticoagulation</li>
<li>Check for pericardial effusion</li>
<li>Chest pain – improves leaning forward, friction rub, distant heart
sounds. Fever/sob. BP low. Tachycardic.</li>
<li><strong>ECG:</strong> Diffuse ST &amp; T wave elevation – not
typically coronary territory. electrical alternans = pericardiocentesis.
Trop leak.</li>
<li><strong>JVP:</strong> Kussmaul’s sign is a paradoxical rise in
jugular venous pressure (JVP) on inspiration</li>
<li><strong>Pulsus paradoxus: aka exaggerated respiratory
variation</strong></li>
<li>Inflate 30mmHg above pulse. Note first intermittent Korotkoff
sounds. (higher systemic BP occurring during expiration). Slowly deflate
cuff until highest BP with continuous beat. The delta is the pulsus
paradoxus. &gt;10mmHg suggest tamponade.</li>
<li><strong>CXR:</strong> Increased cardiac silhouette</li>
<li><strong>ECHO:</strong> Effusion in 50% of uraemic pericarditis.
Repeat echo to ensure resolution 3-5 days.</li>
<li><strong>D.Dx:</strong> Infectious/inflammation(SLE/vasculitis),
neoplastic, meds(hydralazine)</li>
</ul>
<p><br></p>
</div>
<div id="guidelines-protocols" class="section level1">
<h1>Guidelines &amp; Protocols</h1>
<p><a href="https://kdigo.org/guidelines/">KDIGO</a></p>
</div>
<div id="key-papers" class="section level1">
<h1>Key Papers</h1>
<a
href="https://www.nejm.org/doi/full/10.1056/nejmoa1810742">PIVOTAL</a>
<br>
<style>
div.blue { background-color:#e6f0ff; border-radius: 5px; padding: 20px;}
</style>
<div class="blue">
<ul>
<li>notes here</li>
</ul>
</div>
<p><br></p>
</div>
<div id="educational" class="section level1">
<h1>Educational</h1>
<p>links here</p>
</div>
<div id="patient-materials" class="section level1">
<h1>Patient materials</h1>
<p>links here</p>
</div>



</div>
</div>

</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.odd').parent('tbody').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open');
  });
});
</script>

<!-- code folding -->

<script>
$(document).ready(function ()  {

    // temporarily add toc-ignore selector to headers for the consistency with Pandoc
    $('.unlisted.unnumbered').addClass('toc-ignore')

    // move toc-ignore selectors from section div to header
    $('div.section.toc-ignore')
        .removeClass('toc-ignore')
        .children('h1,h2,h3,h4,h5').addClass('toc-ignore');

    // establish options
    var options = {
      selectors: "h1,h2",
      theme: "bootstrap3",
      context: '.toc-content',
      hashGenerator: function (text) {
        return text.replace(/[.\\/?&!#<>]/g, '').replace(/\s/g, '_');
      },
      ignoreSelector: ".toc-ignore",
      scrollTo: 0
    };
    options.showAndHide = false;
    options.smoothScroll = true;

    // tocify
    var toc = $("#TOC").tocify(options).data("toc-tocify");
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
